Efficacy of Selpercatinib in RET-Altered Thyroid Cancers

L. J. Wirth, E. Sherman, B. Robinson, B. Solomon, H. Kang, J. Lorch, F. Worden, M. Brose, J. Patel, S. Leboulleux, Y. Godbert, F. Barlesi, J. C. Morris, T. K. Owonikoko, D. S.W. Tan, O. Gautschi, J. Weiss, C. De La Fouchardière, M. E. Burkard, J. LaskinM. H. Taylor, M. Kroiss, J. Medioni, J. W. Goldman, T. M. Bauer, B. Levy, V. W. Zhu, N. Lakhani, V. Moreno, K. Ebata, M. Nguyen, D. Heirich, E. Y. Zhu, X. Huang, L. Yang, J. Kherani, S. M. Rothenberg, A. Drilon, V. Subbiah, M. H. Shah, M. E. Cabanillas, L. J. Wirth

Research output: Contribution to journalArticlepeer-review

440 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of Selpercatinib in RET-Altered Thyroid Cancers'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science